Example: Heart Attack
Clinical Trials on Yin Deficiency
Total 2 results
-
NCT04806490RecruitingConditions: Yin Deficiency Syndrome
-
NCT02638051CompletedConditions: Peritoneal Neoplasms, Ascites, Yang Deficiency, Yin Deficiency
We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
Medical Conditions
- COVID-19
- Analgesic Efficacy
- Bicuspid
- Cognitively Normal Elderly Individuals
- HER2 Negative Breast Cancer
- Hepatomegaly
- Human Milk Nutrition
- Large Intestine Cancer
- Prehypertension
- Rh Negative Blood Donor
- Stage I Diffuse Large B-Cell Lymphoma
- Tacrolimus-associated Abnormal Glucose Metabolism in Kidney and Liver Transplant Recipients
- Transfusion-dependent Red Blood Cell (RBC) Defect
- Well-trained Athletes
- View Full List
Sponsors and Collaborators
- AblaCare
- Acira
- Asociacio Lleidatana de Respiratori
- Byung-Kiu Park
- CAIO VINICIUS GONÇALVES ROMAN TORRES
- Carl Zeiss Surgical GmbH
- GlycoVaxyn AG
- Lieber Institute for Brain Development
- Luxa Biotechnology, LLC
- Millennium Wellness LLC
- Qibao Community Health Service Center of Shanghai
- University of New England
- the second people hospital of Tibet autonomous region
- View Full List
Drug Interventions
- Amlodipine (5mg)
- Beta Blockers Carvedilol Phosphate
- Clindamycin 900 MG in 6 ML Injection
- Donepezil + placebo
- ES135
- Emodepside (BAY 44-4400)
- Loteprednol/tobramycin
- Placebo for CTP-730
- Pre-procedural High dose atorvastatin loading
- Seretide Diskus (salmeterol/fluticasone) 50/500 μg
- gemigliptin/metformin
- nutrition education plus active supplement
- palbociclib capsule: phase 1 and 2 studies
- View Full List
Conditions
Rare Diseases
Drug Interventions
Dietary Supplements
Sponsor/Collaborators
Locations